Innovis Asset Management’s Aspen Aerogels ASPN Stock Holding History

Innovis Asset Management’s Portfolio ASPN Stock Details ASPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,413	Closed	-$107K	–	163
2023 Q1	$107K	Buy	14,413 +62	+0.4%	+$616	0.04%	158
2022 Q4	$169K	Buy	+14,351	New	+$164K	0.08%	142

Other funds holding ASPN

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Innovis Asset Management's ASPN Position: Q2 2023 in Review

Innovis Asset Management sold out of Aspen Aerogels (ASPN) in Q2 2023, closing a stake of 14,413 shares — an estimated $107K sold.

Innovis Asset Management first reported a position in ASPN in Q4 2022 and held it in 2 quarters. The position peaked at $169K in Q4 2022. 159 funds tracked by Wall St. Rank hold ASPN as of Q2 2023.

Innovis Asset Management reported no remaining Aspen Aerogels position as of Q2 2023 after selling out during the quarter.
Innovis Asset Management sold 14,413 Aspen Aerogels shares in Q2 2023, an estimated $107K.
Innovis Asset Management first reported a position in Aspen Aerogels in Q4 2022 and held it in 2 quarters.
Innovis Asset Management's Aspen Aerogels position peaked at $169K in Q4 2022.
159 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2023.

Based on Innovis Asset Management's 13F filing for Q2 2023, filed 3 Aug 2023.